Depressive disorders and Pharmacotherapy: New info revealed!
Soumya Shraddhya Paul, Amity University, Noida In 2017, depressive disorders were the third biggest cause of non-fatal illness burden worldwide. In the treatment of depressive disorders, pharmacotherapy is an essential component. As of now, the treatment consists of monotherapy using second-generation antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), […]